Synapse

← JEADV Clinical Practice

Papers in JEADV Clinical Practice

Page 13 · newest first

  1. Uncombable hair improved by biotinJEADV Clinical Practice · 2023
  2. Effectiveness and tolerability of calcipotriol/betamethasone aerosol foam in patients with psoriasis vulgaris in real‐life setting: A prospective, noninterventional, multicenter observational study in AustriaJEADV Clinical Practice · 2023
  3. Ear‐looped face masks associated retro‐auricular abscesses during the COVID‐19 pandemicJEADV Clinical Practice · 2023
  4. Prevalence of actinic keratosis and skin cancer in a population of Dutch outdoor workersJEADV Clinical Practice · 2023
  5. Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cellsJEADV Clinical Practice · 2023
  6. Clinical profile of idiopathic angioedema based on severity and treatment response is independent of the presence of concomitant whealsJEADV Clinical Practice · 2023
  7. Scars and environmental factors: Results from a real‐life studyJEADV Clinical Practice · 2023
  8. Efficacy assessment of oxygen flow assisted administration of topical methotrexate (OFA‐MTX5%) for superficial basal cell carcinoma assessed by optical coherence tomographyJEADV Clinical Practice · 2023
  9. The comprehensive impact of pityriasis rubra pilaris on physical symptoms, mental health, and activities of daily living: A mixed methods studyJEADV Clinical Practice · 2023
  10. Prevalence, incidence and relative risk of cardiovascular disease risk factors in adults with atopic dermatitis: A systematic reviewJEADV Clinical Practice · 2023
  11. Forehead lifting with hyaluronic acid filling: A new technique called ‘Crown Lift’JEADV Clinical Practice · 2022
  12. Telemedicine and psoriasis: A review based on statements of the telemedicine working group of the International Psoriasis CouncilJEADV Clinical Practice · 2022
  13. Nonfungible tokens (NFTs) in dermatology and health care: A guide for health care professionalsJEADV Clinical Practice · 2022
  14. Cluster analysis identifies six clinical subtypes of hidradenitis suppurativa characterised by distinct comorbidities, inflammatory and metabolic profiles, patient‐reported outcomes and treatment patternsJEADV Clinical Practice · 2022
  15. Wolf's isotopic response: A case of dermatomal granuloma annulare after COVID‐19 vaccinationJEADV Clinical Practice · 2022
  16. Effect of guselkumab on serum biomarkers in Japanese palmoplantar pustulosis patients in a randomized phase 3 studyJEADV Clinical Practice · 2022
  17. Societal economic burden and determinants of costs for atopic dermatitisJEADV Clinical Practice · 2022
  18. Dermatologists' perspectives on healthcare of patients with atopic dermatitis: A cross‐sectional study in GermanyJEADV Clinical Practice · 2022
  19. Eczema herpeticum and impetigo herpetiformis, is there a link?JEADV Clinical Practice · 2022
  20. Regression of cutaneous squamous cell carcinoma after the development of pembrolizumab‐induced bullous pemphigoidJEADV Clinical Practice · 2022
  21. Neutrophil‐to‐lymphocyte ratio as a cardiovascular risk biomarker in psoriasis: A comprehensive reviewJEADV Clinical Practice · 2022
  22. Evaluating the predictive utility of patient‐oriented scoring of atopic dermatitis (PO‐SCORAD) versus Patient‐Oriented Eczema Measure (POEM) for peanut sensitivity in patients with atopic dermatitisJEADV Clinical Practice · 2022
  23. Sonographic findings of COVID‐Arm: A case seriesJEADV Clinical Practice · 2022
  24. Eosinophilic dermatosis of haematological malignancy (EDHM): A series of nine casesJEADV Clinical Practice · 2022
  25. Generalizability and usefulness of artificial intelligence for skin cancer diagnostics: An algorithm validation studyJEADV Clinical Practice · 2022
  26. Baricitinib for atopic dermatitis patients who responded inadequately to dupilumab treatment: First daily practice resultsJEADV Clinical Practice · 2022
  27. Early intervention and disease memory in psoriasis: A literature reviewJEADV Clinical Practice · 2022
  28. Giant congenital melanocytic naevus caused by NRAS Q61K mosaicismJEADV Clinical Practice · 2022
  29. Adjusted dose regimens in dupilumab treatment for atopic dermatitis: Daily practice experiencesJEADV Clinical Practice · 2022
  30. Real‐life self‐assessment of pruritus relief with a combination of calcipotriol/betamethasone dipropionate foam in patients with plaque psoriasisJEADV Clinical Practice · 2022
  31. A longitudinal comparative study by in vivo harmonic generation microscopy: Q‐switched ruby laser versus picosecond 532‐nm Nd: YAG laser for the treatment of solar lentiginesJEADV Clinical Practice · 2022
  32. Cutaneous reactions post‐COVID‐19 vaccination. Case series and literature reviewJEADV Clinical Practice · 2022
  33. The efficacy of anti‐IL‐1 targeted therapy in PAPA and PASH syndromeJEADV Clinical Practice · 2022
  34. Multidisciplinary panel opinion on the management of bacterial skin infectionsJEADV Clinical Practice · 2022
  35. Depression, anxiety and adjustment disorder among patients with psoriasis receiving systemic agents: A retrospective cohort study in Quebec, CanadaJEADV Clinical Practice · 2022
  36. Self‐reported stigmatisation among patients with atopic dermatitis (AD) or chronic spontaneous urticaria (CSU): A cross‐sectional studyJEADV Clinical Practice · 2022
  37. The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithmsJEADV Clinical Practice · 2022
  38. The spectrum of fibrosing alopeciasJEADV Clinical Practice · 2022
  39. Characteristics of Riehl melanosis in an ethnic Asian population: A comparative study according to age, sex, and hair dye useJEADV Clinical Practice · 2022
  40. EORTC‐QLQ‐C30 and SKINDEX‐29 measurement of health‐related quality of life in patients with mycosis fungoides and Sézary syndrome: Real‐world data in Spanish patients (MICADOS Study)JEADV Clinical Practice · 2022
  41. Scabies and therapeutic resistance: Current knowledge and future perspectivesJEADV Clinical Practice · 2022
  42. Improvement of photoprotection with sunscreen formulas containing the cyclic merocyanine UVA1 absorber MCE: In vivo demonstration under simulated and real sun exposure conditions in three randomised controlled trialsJEADV Clinical Practice · 2022
  43. Risk of respiratory tract infections and serious infections in psoriasis patients treated with biologics: Results from the BioCAPTURE registryJEADV Clinical Practice · 2022
  44. Leveraging web search data to explore public interest in psoriasis in GermanyJEADV Clinical Practice · 2022
  45. Negative emotional impact following botulinum toxin treatment for crow's feet linesJEADV Clinical Practice · 2022
  46. Associations among bullous pemphigoid and various neurological diseases: A systematic review and meta‐analysisJEADV Clinical Practice · 2022
  47. A plaque on the face of a 4‐year‐old boyJEADV Clinical Practice · 2022
  48. The role of nurses in the management of atopic dermatitis: Results of an international surveyJEADV Clinical Practice · 2022
  49. The body distribution of scabies skin lesionsJEADV Clinical Practice · 2022
  50. Skin manifestations associated with checkpoint inhibitorsJEADV Clinical Practice · 2022